Patents by Inventor Jean-Francois Brazeau

Jean-Francois Brazeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carboxylic Acid Containing Indanyl Compounds for the Treatment of Neurodegenerative Diseases
    Publication number: 20240376048
    Abstract: Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases. Formula (I).
    Type: Application
    Filed: December 7, 2022
    Publication date: November 14, 2024
    Applicant: Celgene Corporation
    Inventors: Jean-Francois Brazeau, Rulin Ma, Jeffrey M. Schkeryantz, Karin Worm, Patrick W. Papa
  • Carboxylic Acid Containing Indanyl Compounds for the Treatment of Neurodegenerative Diseases
    Publication number: 20240124394
    Abstract: Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.
    Type: Application
    Filed: December 22, 2021
    Publication date: April 18, 2024
    Applicant: Celgene Corporation
    Inventors: Jeffrey M. Schkeryantz, Julie Selkirk, Philip Stewart Turnbull, Junko Tamiya, Patrick W. Papa, Jean-Francois Brazeau, Karin Worm